PT - JOURNAL ARTICLE AU - Anna M Maw AU - Carolina Ortiz-lopez AU - Megan A Morris AU - Christine Jones AU - Elaine Gee AU - Stephan Tchernodrinski AU - Henry Kramer AU - Benjamin T Galen AU - Amanda F Dempsey AU - Nilam Soni TI - Hospitalist perspectives of available tests to monitor volume status in patients with heart failure: a qualitative study AID - 10.1101/2020.06.01.20119727 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.01.20119727 4099 - http://medrxiv.org/content/early/2020/06/05/2020.06.01.20119727.short 4100 - http://medrxiv.org/content/early/2020/06/05/2020.06.01.20119727.full AB - Acute decompensated heart failure is the leading admitting diagnosis in patients 65 and older with more than 1 million hospitalizations per year in the US alone. Traditional tools to evaluate for and monitor volume status in patients with heart failure, including symptoms and physical exam findings, are known to have limited accuracy. In contrast, point of care lung ultrasound is a practical and evidenced-based tool for monitoring of volume status in patients with heart failure. However, few inpatient clinicians currently use this tool to monitor diuresis. We performed semi-structured interviews of 23 hospitalists practicing in 5 geographically diverse academic institutions in the US to better understand how hospitalists currently assess and monitor volume status in patients hospitalized with heart failure. We also explored their perceptions and attitudes toward adoption of lung ultrasound. Hospitalist participants reported poor reliability and confidence in the accuracy of traditional tools to monitor diuresis and expressed interest in learning or were already using lung ultrasound for this purpose. The time required for training and access to equipment that does not impede workflow were considered important barriers to its adoption by interviewees.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by NHLBI grant K12 HL137862:Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Colorado IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is available